Literature DB >> 11344100

Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival.

N Reinmuth1, W Liu, Y D Jung, S A Ahmad, R M Shaheen, F Fan, C D Bucana, G McMahon, G E Gallick, L M Ellis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11344100     DOI： 10.1096/fj.00-0693fje

Source DB:  PubMed          Journal:  FASEB J        ISSN： 0892-6638            Impact factor:   5.191


× No keyword cloud information.
  61 in total

1.  PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival.

Authors:  Steven Song; Andrew J Ewald; William Stallcup; Zena Werb; Gabriele Bergers
Journal:  Nat Cell Biol       Date:  2005-08-21       Impact factor: 28.824

2.  Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102.

Authors:  Barbara Sennino; Beverly L Falcón; Dilara McCauley; Tom Le; Thomas McCauley; Jeffrey C Kurz; Amy Haskell; David M Epstein; Donald M McDonald
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

Review 3.  The role of pericytes in blood-vessel formation and maintenance.

Authors:  Gabriele Bergers; Steven Song
Journal:  Neuro Oncol       Date:  2005-10       Impact factor: 12.300

Review 4.  Role of NRP-1 in VEGF-VEGFR2-Independent Tumorigenesis.

Authors:  Chenxi Hu; Xiaodong Jiang
Journal:  Target Oncol       Date:  2016-08       Impact factor: 4.493

5.  Angiogenesis and melanoma - from basic science to clinical trials.

Authors:  Maxine Sylvia Emmett; Daemon Dewing; Rowan Oliver Pritchard-Jones
Journal:  Am J Cancer Res       Date:  2011-08-08       Impact factor: 6.166

Review 6.  New approaches in angiogenic targeting for colorectal cancer.

Authors:  Aleix Prat; Esther Casado; Javier Cortés
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

Review 7.  Current and emerging therapies for corneal neovascularization.

Authors:  Danial Roshandel; Medi Eslani; Alireza Baradaran-Rafii; Albert Y Cheung; Khaliq Kurji; Sayena Jabbehdari; Alejandra Maiz; Setareh Jalali; Ali R Djalilian; Edward J Holland
Journal:  Ocul Surf       Date:  2018-06-20       Impact factor: 5.033

8.  A phase I surrogate endpoint study of SU6668 in patients with solid tumors.

Authors:  Henry Q Xiong; Roy Herbst; Silvana C Faria; Catherine Scholz; Darren Davis; Edward F Jackson; Timothy Madden; David McConkey; Marshall Hicks; Kenneth Hess; Chusilp Arthur Charnsangavej; James L Abbruzzese
Journal:  Invest New Drugs       Date:  2004-11       Impact factor: 3.850

9.  Molecular mechanisms of resistance to tumour anti-angiogenic strategies.

Authors:  Renaud Grépin; Gilles Pagès
Journal:  J Oncol       Date:  2010-03-09       Impact factor: 4.375

10.  Hsp90 as a gatekeeper of tumor angiogenesis: clinical promise and potential pitfalls.

Authors:  J E Bohonowych; U Gopal; J S Isaacs
Journal:  J Oncol       Date:  2010-06-24       Impact factor: 4.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.